Skip to main content
See every side of every news story
Published loading...Updated

FDA Under Pressure From Right After Abortion Pill Approval

Summary by The Hill
The anti-abortion movement’s patience with the Food and Drug Administration (FDA) is wearing thin following the agency’s recent approval of a second generic version of mifepristone, one of two drugs taken for a medication abortion.   President Trump repeatedly pledged during the campaign last year that he would leave abortion policy to the states, but…

7 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Tablet broke the news in on Friday, October 3, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal